PAI-1 and uPA as Biomarkers in Breast Cancer: From Pilot Studies to Recommendation for Clinical Use

被引：0
|
作者：
Duffy, M. J. [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland
来源：
TUMOR BIOLOGY | 2008年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [21] PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells
    Alvarez-Millán, JJ
    Bocos, C
    Ferrín, V
    Lucas, AR
    Ruibal, A
    Schneider, J
    [J]. ONCOLOGY, 2002, 62 (03) : 286 - 290
  • [22] European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer
    Marguet, Sophie
    Mazouni, Chafika
    Ramaekers, Bram L. T.
    Dunant, Ariane
    Kates, Ronald
    Jacobs, Volker R.
    Joore, Manuela A.
    Harbeck, Nadia
    Bonastre, Julia
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 63 : 168 - 179
  • [23] Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue
    Susanne Haas
    Tjoung-Won Park
    Jens Claus Hahne
    Hans-Peter Fischer
    [J]. Virchows Archiv, 2008, 452 : 277 - 283
  • [24] Association of uPA, PAI-1, and uPAR in nipple aspirate fluid (NAF) with breast cancer
    Qin, WY
    Zhu, WZ
    Wagner-Mann, C
    Folk, W
    Sauter, ER
    [J]. CANCER JOURNAL, 2003, 9 (04): : 293 - 301
  • [25] Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue
    Haas, Susanne
    Park, Tjoung-Won
    Hahne, Jens Claus
    Fischer, Hans-Peter
    [J]. VIRCHOWS ARCHIV, 2008, 452 (03) : 277 - 283
  • [26] UPA/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays
    Lamy, P. -J.
    Romieu, G.
    Jacot, W.
    [J]. BULLETIN DU CANCER, 2010, 97 (03) : 341 - 348
  • [27] uPA/PAI-1, Oncotype DX™, MammaPrint®. Prognosis and predictive values for clinical utility in breast cancer management
    Luporsi, Elisabeth
    Bellocq, Jean-Pierre
    Barriere, Jerome
    Bonastre, Julia
    Chetritt, Jerome
    Le Corroller, Anne-Gaelle
    de Cremoux, Patricia
    Fina, Frederic
    Gauchez, Anne-Sophie
    Lamy, Pierre-Jean
    Martin, Pierre-Marie
    Mazouni, Chafika
    Peyrat, Jean-Philippe
    Romieu, Gilles
    Verdoni, Laetitia
    Mazeau-Woynar, Valerie
    Kassab-Chahmi, Diana
    [J]. BULLETIN DU CANCER, 2015, 102 (09) : 719 - 729
  • [28] Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer
    Maerkl, Bruno
    Kazik, Martin
    Harbeck, Nadia
    Jakubowicz, Elzbieta
    Hoffmann, Reinhard
    Jung, Thomas
    Steinfeld, Dieter
    Schenkirsch, Gerhard
    Schlimok, Guenter
    Oruzio, Daniel
    [J]. BMC CANCER, 2019, 19 (1)
  • [29] uPA/PAI-1, Oncotype DX™, MammaPrint®. Prognosis and predictive values for clinical utility in breast cancer management
    Bellocq, Jean-Pierre
    Luporsi, Elisabeth
    Barriere, Jerome
    Bonastre, Julia
    Chetritt, Jerome
    Le Corroller, Anne-Gaelle
    de Cremoux, Patricia
    Fina, Frederic
    Gauchez, Anne-Sophie
    Kassab-Chahmi, Diana
    Lamy, Pierre-Jean
    Martin, Pierre-Marie
    Mazouni, Chafika
    Peyrat, Jean-Philippe
    Romieu, Gilles
    Verdoni, Laetitia
    Mazeau-Woynar, Valerie
    [J]. ANNALES DE PATHOLOGIE, 2014, 34 (05) : 349 - 351
  • [30] Clinical significance and future of the prognostic factors uPA and PAI-1 for nodal-negative invasive breast cancer
    Streckert, I
    Bonatz, G.
    Kucharski, K.
    Marek, W.
    Streckert, H. J.
    Phillipou, S.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (03) : 304 - 304
12345